Portfolio company
Trod Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
Francis Medical
This company develops water vapor ablation systems used by physicians to treat prostate, kidney and bladder cancers.
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
ProVerum Medical
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
Biobot Surgical
This company develops robotic needle guidance systems and image fusion software for hospitals and clinics to perform prostate cancer diagnosis and treatment.
HEPTA Medical
This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.
Promaxo, Inc
The company develops a point-of-care MRI platform for urologists to perform guided prostate biopsies and treatments in clinical settings.